フロリダ州における頭頸部扁平上皮癌の臨床試験
フロリダ州内の拠点で、頭頸部扁平上皮癌に関する53件の研究が参加者を募集しています。
フロリダ州内の都市
- Orlando16件の研究
- Tampa15件の研究
- Miami14件の研究
- Jacksonville12件の研究
- Sarasota6件の研究
- Plantation4件の研究
- St. Petersburg4件の研究
- Gainesville3件の研究
- Kendall3件の研究
- Deerfield Beach3件の研究
- Spring Hill3件の研究
- Hollywood3件の研究
公式研究テキスト（英語）
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0148, Jacksonville
- Site #0136, Palm Bay
- Site #0105, Tampa
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06788990Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #48, Celebration
- Exelixis Clinical Site #11, Gainesville
- Exelixis Clinical Site #78, Jacksonville
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Mount Sinai Medical Center, Miami Beach
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06589804A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 7, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Mayo Clinic, Jacksonville
- Moffit Cancer center, Tampa
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/25更新 · NCT07219212BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Florida Cancer Specialists South, Fort Myers
- University of Miami Sylvester Comprehensive Cancer Center, Miami
- AdventHealth Medical Group Oncology and Hematology at Orlando, Orlando
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07276399JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- Mayo Clinic Jacksonville, Jacksonville
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
被験者募集中第3相
60歳以上 · 全性別 · 2026/09/25更新 · NCT04892173Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- 他5件
被験者募集中第2相
18歳〜79歳 · 全性別 · 2026/09/22更新 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Sylvester Comprehensive Cancer Center, Miami
- Sara Cannon Research Institute Lake Nona, Orlando
- Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sylvester Comprehensive Cancer Center - Miami, Miami
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Florida Cancer Specialists - Lake Nona, Orlando
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Holy Cross Hospital, Fort Lauderdale
- 他9件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02734537ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- University of Miami, Miami
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06657222A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Mayo Clinic Florida, Jacksonville
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/03更新 · NCT06163534A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Florida Cancer Specialists, Sarasota
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07602842Intralesional Chemotherapy (IC): Cisplatin + Epinephrine
- University of Miami, Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07392580A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Orlando Health, Orlando
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06769698Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
16歳以上 · 全性別 · 2026/08/20更新 · NCT05269381Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Sarasota Memorial Hospital-Venice, N. Venice
- Moffitt Cancer Center at SouthShore, Ruskin
- Florida Cancer Specialists - Sarasota, Sarasota
- 他8件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- Bay Pines VA Healthcare System, Bay Pines
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07441681SMP-3124LP in Adults With Advanced Solid Tumors
- Advent Health, Celebration
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06526819A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- University of Florida, Gainesville
- Sarah Cannon Research Institute (Lake Nona), Orlando
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Florida Cancer Specialists - Lake Nona, Orlando
- Florida Cancer Specialists - Sarasota, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06150664First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- American Oncology Partners, PA. a Florida professional service corporation, d/b/a Vista Oncology, Fort Myers
- Florida Cancer Specialists & Research Institute, LLC, Fort Myers
- Memorial Cancer Institute, Hollywood
- 他4件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Florida Cancer Specialists, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/18更新 · NCT07503808A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, St. Petersburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/26更新 · NCT06256588DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA08-0, Florida City
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06953089Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
- University of Florida, Gainesville
- UF Health Proton Therapy Institute, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/24更新 · NCT05268614A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
- Miami Cancer Institute, Miami
被験者募集中第2/3相
18歳〜100歳 · 全性別 · 2026/04/23更新 · NCT05893888A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- AdventHealth Medical Group Oncology & Hematology at Orlando, Orlando
- Moffitt Cancer Center, Tampa
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877A Study of VET3-TGI in Patients With Solid Tumors
- University of Miami, Miami
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/07更新 · NCT06444815A Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
- BRCR global, Plantation
- Florida Cancer Specialists, Sarasota
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/06更新 · NCT05785741ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。